Inhibition of GSK-3β has been suggested as a therapeutic target in many disease including diabetes and Alzheimer's disease.28, 29 Thus, we suggest that it could also be a therapeutic target in diabetic retina. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.